Literature DB >> 35896757

Arterial to end-tidal CO2 gradients during isocapnic hyperventilation.

Jennifer Jouwena1,2,3, Sarah A Eerlings4,5,6, Andre M De Wolf7, Lieve Van Hoovels8, Arne Neyrinck5,6, Marc Van de Velde5,6, Jan F A Hendrickx4,5,6,9.   

Abstract

Isocapnic hyperventilation (ICHV) is occasionally used to maintain the end-expired CO2 partial pressure (PETCO2) when the inspired CO2 (PICO2) rises. Whether maintaining PETCO2 with ICHV during an increase of the PICO2 also maintains arterial PCO2 (PaCO2) remains poorly documented. 12 ASA PS I-II subjects undergoing a robot-assisted radical prostatectomy (RARP) (n = 11) or cystectomy (n = 1) under general endotracheal anesthesia with sevoflurane in O2/air (40% inspired O2) were enrolled. PICO2 was sequentially increased from 0 to 0.5, 1.0, 1.5 and 2% by adding CO2 to the inspiratory limb of the circle system, while increasing ventilation to a target PETCO2 of 4.7-4.9% by adjusting respiratory rate during controlled mechanical ventilation. Pa-ETCO2 gradients were determined after a 15 min equilibration period at each PICO2 level and compared using ANOVA. Mean (standard deviation) age, height, and weight were 66 (6) years, 171 (6) cm, and 75 (8) kg, respectively. Capnograms were normal and hemodynamic parameters remained stable. PETCO2 could be maintained within 4.7-4.9% in all subjects at all times except in 1 subject with 1.5% PICO2 and 5 subjects with 2.0% PICO2; data from the one subject in whom both 1.5 and 2.0% PICO2 resulted in PETCO2 > 5.1% were excluded from analysis. Pa-ETCO2 gradients did not change when PICO2 increased. The effect of a modest rise of PICO2 up to 1.5% on PETCO2 during RARP can be readily overcome by increasing ventilation without altering the Pa-ETCO2 gradients. At higher PICO2, airway pressures may become a limiting factor, which requires further study.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  CO2; Capnometry; Dead space ventilation; Gradient; Isocapnic hyperventilation; Rebreathing

Year:  2022        PMID: 35896757     DOI: 10.1007/s10877-022-00893-3

Source DB:  PubMed          Journal:  J Clin Monit Comput        ISSN: 1387-1307            Impact factor:   1.977


  4 in total

1.  Evaluation of a method for isocapnic hyperventilation: a clinical pilot trial.

Authors:  K Hallén; P Jildenstål; O Stenqvist; S-E Ricksten; S Lindgren
Journal:  Acta Anaesthesiol Scand       Date:  2017-10-16       Impact factor: 2.105

2.  Reply to: Life cycle assessment of memsorb use.

Authors:  Sarah A Eerlings; Andre M De Wolf; Jan F A Hendrickx
Journal:  J Clin Monit Comput       Date:  2022-04-25       Impact factor: 1.977

3.  In vitro performance of prefilled CO₂ absorbers with the Aisys®.

Authors:  Jan F A Hendrickx; Simon P A J De Ridder; Alexander Dehouwer; Rik Carette; Sofie De Cooman; Andre M De Wolf
Journal:  J Clin Monit Comput       Date:  2015-05-08       Impact factor: 2.502

4.  Memsorb™, a novel CO2 removal device part II: in vivo performance with the Zeus IE®.

Authors:  Sarah A Eerlings; Mohammed K Bashraheel; Andre M De Wolf; Arne Neyrinck; Marc Van de Velde; Geert Vandenbroucke; Rik Carette; Jeffrey Feldman; Jan F A Hendrickx
Journal:  J Clin Monit Comput       Date:  2022-02-01       Impact factor: 2.502

  4 in total
  1 in total

1.  Life cycle assessment of memsorb use.

Authors:  Alain F Kalmar; Pascal Verdonck
Journal:  J Clin Monit Comput       Date:  2022-03-17       Impact factor: 1.977

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.